SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001240017-04-000002
Filing Date
2004-12-17
Accepted
2004-12-17 15:23:15
Documents
1
Period of Report
2004-12-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4284
  Complete submission text file 0001240017-04-000002.txt   6031
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Issuer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
VASICEK THOMAS J (Reporting) CIK: 0001240017 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22570 | Film No.: 041211265